edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: IRLAB Therapeutics
Edison Investment Research has terminated coverage on IRLAB Therapeutics (IRLAB-A). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.
IRLAB Therapeutics — 7 videos in collection
Based in Scandinavia, IRLAB Therapeutics is dedicated to discovering and developing new drugs for treating Parkinson’s disease and other life-altering illnesses that affect the central nervous system. In this interview, IRLAB’s executive vice president and head of R&D (previously CEO) Nicholas Waters provides an update on the company’s strategy and pipeline.
Get access to the very latest content matched to your personal investment style.